Longevium Raises US$7M to Launch AI Longevity Research Lab in Dubai

Ksenia Butova, CEO & founder of Longevium

Dubai-based longevity healthcare company Longevium has secured US$7 million in its first funding round to establish an AI-powered Longevity Research Laboratory at Dubai Science Park, marking another milestone in the UAE's expanding healthtech and artificial intelligence ecosystem.

Scheduled to open in Q4 2026, the research centre aims to accelerate the development of preventive healthcare technologies that help people live longer, healthier lives. Rather than operating as a clinical treatment facility, the laboratory will serve as a dedicated research and development hub where artificial intelligence, biomedical science, and clinical expertise converge to create next-generation longevity technologies.

The investment comes as the global longevity economy continues to gain momentum. According to industry estimates, the global longevity and anti-ageing market is projected to exceed US$600 billion by 2030, driven by ageing populations, advances in AI, and growing demand for preventive healthcare.

How Does the Project Support Dubai's Healthcare and AI Strategy?

The laboratory aligns closely with Dubai's broader healthcare innovation agenda, including the establishment of the Dubai Longevity Authority, which was launched to position the emirate as a global destination for longevity research, preventive medicine, and healthy ageing.

Its location within Dubai Science Park, one of the UAE's leading life sciences and research ecosystems, further strengthens collaboration opportunities across biotechnology, pharmaceuticals, and healthcare innovation.

The announcement also complements the UAE's wider AI ecosystem, supported by organizations such as Hub71, Abu Dhabi Global Market (ADGM), and government initiatives promoting advanced healthcare, biotechnology, and deep-tech commercialization.

Together, these initiatives reinforce the UAE's ambition to become a regional hub for AI-driven healthcare innovation while attracting international researchers, startups, and investment into life sciences.

What Will the US$7 Million Funding Be Used For?

The newly raised capital will fund the laboratory's construction, research infrastructure, and development of advanced longevity technologies.

Investment Area	Purpose
AI Research Infrastructure	Build the Longevity AI Research Laboratory at Dubai Science Park
Digital Twins	Simulate personalized treatment pathways before clinical implementation
Regenerative Medicine	Develop therapies to repair or regenerate damaged tissues and organs
Advanced Diagnostics	Create AI-enabled technologies for early disease detection
Clinical Research	Support preventive medicine and healthy ageing studies

Which Technologies Will Longevium Research?

The research facility will investigate multiple technologies that combine artificial intelligence with advanced biomedical science to improve preventive healthcare.

Its core research priorities include:

• AI-powered digital twins that allow physicians to model personalized treatment strategies before real-world application.
• Biological ageing analysis to measure an individual's true physiological age instead of chronological age.
• Regenerative medicine and tissue engineering to restore damaged organs and improve long-term health outcomes.
• Advanced cell therapies designed to repair tissues and combat age-related diseases.
• Swallowable robotic imaging capsules for less invasive internal diagnostics.
• AI-powered skin cancer scanners capable of detecting abnormalities earlier.
• Smart contact lenses that analyze tear fluid to continuously monitor health biomarkers.
• Noble gas therapies exploring the therapeutic potential of xenon, argon, helium, and krypton for organ protection, neurological disorders, and stress-related conditions.

Why Is AI Becoming Central to Longevity Medicine?

Artificial intelligence is rapidly transforming longevity research by enabling scientists to analyze vast biological datasets, predict disease risks earlier, and personalize healthcare interventions.

AI-powered digital twins, predictive analytics, and continuous health monitoring technologies could significantly improve preventive care while reducing healthcare costs associated with chronic diseases. These capabilities are becoming increasingly important as countries prepare for ageing populations and rising healthcare expenditures throughout the coming decades.

For Dubai, investments such as Longevium's laboratory demonstrate how AI is moving beyond productivity applications into high-value scientific research capable of creating new healthcare industries.

What Does This Mean for the UAE Healthtech Ecosystem?

Longevium's expansion reflects growing investor confidence in the UAE's healthtech sector, where government-backed innovation initiatives continue attracting companies developing AI, biotechnology, precision medicine, and preventive healthcare solutions.

As facilities like the Longevity AI Research Laboratory become operational, the UAE is strengthening its position alongside leading global innovation hubs in life sciences while creating opportunities for startups, researchers, healthcare providers, and investors seeking to commercialize next-generation medical technologies.

 

 

FAQs

1. What is Longevium?
Longevium is a Dubai-based healthcare technology company focused on longevity science, preventive medicine, and AI-powered healthcare innovation.

2. How much funding did Longevium raise?
Longevium raised US$7 million in its first funding round to establish an AI-powered Longevity Research Laboratory at Dubai Science Park.

3. When will the Longevity AI Research Laboratory open?
The research facility is scheduled to begin operations in Q4 2026.

4. What technologies will the laboratory develop?
The laboratory will research AI-powered digital twins, biological ageing measurement, regenerative medicine, tissue engineering, advanced diagnostics, robotic imaging technologies, smart contact lenses, and noble gas therapies.

5. Why is Dubai investing in longevity research?
Dubai aims to become a global hub for preventive healthcare and longevity medicine through initiatives such as the Dubai Longevity Authority, AI-driven healthcare investments, and life sciences infrastructure like Dubai Science Park.